Cervical Intraepithelial Neoplasia (CIN)

Management of abnormal cervical screening results.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Women's HealthOncology

Clinical Guidelines

Cervical screening care pathway - GOV.UK
National
CKS: Cervical screening
National
European Guidelines for Quality Assurance in Cervical Cancer Screening: Recommendations for clinical management of abnormal cervical cytology, including cervical intraepithelial neoplasia
National
European Quality Standards for the Treatment of Cervical Intraepithelial Neoplasia (CIN) 2007
National
WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention
National
WHO guidelines for treatment of cervical intraepithelial neoplasia 2–3 and adenocarcinoma in situ
National
2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors (ASCCP)
Local
Cervical Cancer: Screening (USPSTF Recommendation Statement)
Local
ESMO Clinical Practice Guideline: Cervical cancer
Local
Human Papillomavirus (HPV) Infection - STI Treatment Guidelines (CDC)
Local
Practice Bulletin No. 157: Cervical Cancer Screening and Prevention (ACOG)
Local
WHO guidelines for treatment of cervical intraepithelial neoplasia 2–3 and adenocarcinoma in situ
Local